We're delighted to announce that Good Morning Britain presenter, Sean Fletcher, has become an Ambassador for the charity.
Earlier this year, Sean ran the London Marathon on behalf of the charity and highlighted the issue of bowel cancer on ITV's Good Morning Britain, talking about how his family have been affected by the disease.
We were delighted to be recognised at the Third Sector Awards in central London last night. The charity had been shortlisted for the Fundraising team of the Year.
Director of Fundraising, Graham Kelly said: “We’re incredibly proud of being shortlisted for this prestigious award and grateful to all those who contributed to our fundraising total last year. This includes Beating Bowel Cancer's fantastic team of staff and supporters and all those individuals and organisation who donated to our campaigns.
Colorectal clinical nurse specialists Paula Brayford and Sarah Thompson have won national awards for their outstanding work with bowel cancer patients.
Paula Brayford, who works for the ShrewsburyTelford Hospital NHS Trust, and Sarah Thompson, from the Guy’s and St Thomas’ NHS Foundation Trust, received their award from us at a conference on Monday 21 September.
According to a report published in the Journal of Medical Screening today, more than half of people invited to take a new bowel cancer screening test didn’t take up the opportunity.
The report from Cancer Research UK shows that those from poorer neighbourhoods were less likely to take up the bowel scope screening test, with only one third in the most deprived neighbourhoods going for their appointment compared to over half in the most affluent.
The media today have reported that differences in access to key NHS services, including cancer care, are putting patients at risk,
The NHS Atlas of Variation - published by NHS England and Public Health England - looks at service performance in more than 200 local areas.
The NHS has announced a new national training programme which will give an additional 200 staff the skills and expertise to carry out endoscopies by 2018. Endoscopies are tests where the inside of your body can be examined for cancer.
This is in addition to the extra 250 gastroenterologists the NHS has already committed to train by 2020. These newly trained staff will together be able to carry out over a half a million more endoscopy tests on the NHS by 2020.
We are thrilled to annouce that Ben has been shortlisted along with 3 others for the Pride of Granada award. The winner of this award will go on to represent the North West in the Fundraiser category at the Daily Mirror Pride of Britain Awards.
Ben Ashworth, 36, was diagnosed with terminal bowel cancer. Undeterred by his diagnosis, Ben has run 17 marathons for charity over 17 months.
With further changes to the Cancer Drugs Fund in England announced today, we outline what this means for bowel cancer patients.
NHS England announced today that more life-extending bowel cancer treatments will be removed from the Cancer Drugs Fund.
The treatments affected are:
Bevacizumab (Avastin®) will no longer be funded by the Cancer Drugs Fund to treat advanced bowel cancer.
Cetuximab (Erbitux®) will now only be funded as a 1st line treatment in combination with FOLFOX chemotherapy (Oxaliplatin + 5FU) or FOLFORI chemotherapy (Irinotecan + 5FU)
According to a new report from Cancer Research UK, thousands of cancer patients are missing out on personalised treatments each year in England because they are not being tested to see if they might benefit from them.
These tests identify the genetic faults underlining a patient’s cancer some of which can benefit from targeted therapies. The report focused on patients with skin, lung and bowel cancer, as targeted drugs are available on the NHS for these cancer types.
A record number of people in Scotland are using bowel cancer screening tests but poorer people are less likely to take the test, as figures reveal a significant gap between wealthy and people from less affluent areas.
Even though more than a million people in Scotland have taken the test,results still fall short of the 60 per cent standard set by Healthcare Improvement Scotland.